Troy Lister serves as Executive at Verve Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Troy Lister has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 25, 2025 involved transacting 6,952 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jul 25, 2025 | VERV | $0 | Tender | 6,952 | $N/A | Discretionary |
Troy Lister currently holds 0 shares of Verve Therapeutics, Inc. (VERV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Troy Lister has been a net neutral trader of VERV stock. They have purchased $0 and sold $0 worth of shares.
Troy Lister's most recent insider trade was on Jul 25, 2025, when they sold 6,952 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted